Boston Scientific (BSX) Reports Positive Late-Breaking Data from INTREPID Study
April 24, 2018 6:35 AM
Boston Scientific Corporation (NYSE: BSX) today announced one-year data from the INTREPID study, the first and only prospective, double-blind, randomized ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
